Aug. 27,  2025 – Qureight recently announced that it has been selected by Calluna Pharma to support its Phase 2 AURORA study. Qureight will analyze imaging data from adult patients, evaluating anatomical lung changes in individuals treated with CAL101, Calluna’s lead asset for the treatment of idiopathic pulmonary fibrosis (IPF).

Aug. 27, 2025 — Bayer has announced that a New Drug Application (NDA) for its investigational contrast agent gadoquatrane has been accepted for review by the U.S. Food and Drug Administration (FDA). The NDA for gadoquatrane has been filed for contrast-enhanced magnetic resonance imaging of the CNS and other body regions in adults and pediatric patients, including neonates.

Aug. 26, 2025 — Core Sound Imaging, the company behind the widely established Studycast medical imaging workflow platform, has acquired UltraLinQ Healthcare Solutions, a provider of cloud-based PACS and cardiac monitoring solutions. This platform expansion is part of Studycast's strategic growth initiative to consolidate strong imaging solutions under one robust platform.

Aug. 21, 2025 — On Aug. 21, 2025, Nusano, a physics company transforming the production of radioisotopes, cut the ribbon on its 190,000-square-foot radioisotope production facility in West Valley City, Utah. The site will be capable of producing more than 40 different radioisotopes for use in cancer diagnostics and therapeutics, as well as industrial applications, such as long-lived nuclear batteries.

Aug. 26, 2025 — Optellum, a global leader in AI for lung health, recently announced the world’s first thorax CT foundation model built for precision lung care in real-world settings — an ambitious initiative aiming to revolutionize the early detection and management of lung diseases, with an initial focus on lung cancer.

Aug. 21, 2025 — The medical imaging market is projected to have a compound annual growth rate of nearly six percent over the next seven years.


The Digital Imaging and Communications in Medicine (DICOM) standard is the bedrock of interoperability, yet achieving its full potential within complex hospital environments remains a challenge. This is a particular challenge for pathology, where legacy infrastructure means it has the furthest to go to achieve DICOM standardization.

But the clock is ticking. So, let's be realistic. Instead of waiting for the DICOM utopia, we should embrace middleware as a pragmatic solution to quickly bridge the gap between existing systems and modern applications.

Aug. 22, 2025 — Esaote recently announced that the MyLab A50 and MyLab A70 ultrasound systems have received FDA approval. Previously unveiled to the international medical community, these advanced platforms are now cleared for distribution in the United States, underscoring Esaote's ongoing commitment to innovation in diagnostic imaging.

August 18, 2025 – Akumin, a national leader in outpatient radiology and oncology services, has selected Lunit INSIGHT DBT, a leading AI solution for early breast cancer detection. The decision marks a key step in Akumin’s plans to integrate advanced technologies that elevate care delivery and expand patient access to precision diagnostics. 

Aug. 19, 2025 — According to the latest study from BCC Research, the "Global Mammography Equipment Markets" is projected to grow from $3.1 billion in 2025 to $4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 5.2% from 2025 through 2030.

This report provides a detailed review of the global mammography equipment market, highlighting current technologies, growth drivers and emerging opportunities. The report segments by equipment type, end-user industry, and region.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now